Kroeger KM et al. Effects of stimulus and cell type on the expression of the tumor necrosis factor promoter polymorphism. Cytokine 2000; 12: 1108-14.
Louis E et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401-6.
Santos AR et al. Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy. J Infect Dis 2002; 186: 1687-91.
Hajeer AH, Hutchinson IV. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol 2001; 62: 1191-9.
Alvarez V et al. Association between the TNFalpha -308 A/G polymorphism and the onset-age of Alzheimer disease. Am J Med Genet 1999; 88: 496-8.
Andersen-Ranberg K et al. Healthy centenarians do not exist, but autonomous centenarians do: A population-based study of morbidity among Danish centenarians. J Am Geriatr Soc 2001; 49: 900-8.
Bruunsgaard H et al. Predicting death from TNF-alpha and IL-6 in 80-year-old people. Clin Exp Immunol 2003; 132: 24-31.
Barger SW et al. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: Evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca accumulation. Proc Natl Acad Sci U S A 1995; 92: 9328-32.
Brucki SM et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 1999; 5: 788-94.
Tarkowski E et al. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease andPROCESSED TEXT: physical disabilities